Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Microsoft
MSFT
|
+$928M |
| 3 |
McDonald's
MCD
|
+$762M |
| 4 |
Amazon
AMZN
|
+$716M |
| 5 |
Coca-Cola
KO
|
+$650M |
Top Sells
| 1 |
Charles Schwab
SCHW
|
+$1.78B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.22B |
| 3 |
Strategy Inc Common Stock Class A
MSTR
|
+$625M |
| 4 |
Kroger
KR
|
+$547M |
| 5 |
Danaher
DHR
|
+$504M |
Sector Composition
| 1 | Technology | 16.69% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 12.79% |
| 4 | Financials | 12.71% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BELFB
2526
Bel Fuse Class B
BELFB
$1.88B
| $2.29M | ﹤0.01% |
+23,465
| New | +$2.29M |
|
|
SAFE
2527
Safehold
SAFE
$1.17B
| $2.29M | ﹤0.01% |
147,231
+85,575
| +139% | +$1.33M |
|
|
AUTL
2528
Autolus Therapeutics
AUTL
$351M
| $2.29M | ﹤0.01% |
1,004,378
+815,470
| +432% | +$1.86M |
|
2529
Jasper Therapeutics
JSPR
$39.5M
| $2.28M | ﹤0.01% |
410,444
+35,274
| +9% | +$196K |
|
2530
Kodak
KODK
$481M
| $2.28M | ﹤0.01% |
403,072
+49,096
| +14% | +$277K |
|
2531
Fidelity Enhanced Large Cap Value ETF
FELV
$2.44B
| $2.28M | ﹤0.01% |
71,647
+49,459
| +223% | +$1.57M |
|
2532
iShares ESG Advanced MSCI USA ETF
USXF
$1.27B
| $2.27M | ﹤0.01% |
42,184
-34,317
| -45% | -$1.85M |
|
2533
10x Genomics
TXG
$1.63B
| $2.27M | ﹤0.01% |
195,944
-868,322
| -82% | -$10.1M |
|
2534
ProShares Ultra Financials
UYG
$894M
| $2.27M | ﹤0.01% |
23,736
+5,759
| +32% | +$550K |
|
2535
SPS Commerce
SPSC
$4.06B
| $2.27M | ﹤0.01% |
16,662
-24,639
| -60% | -$3.35M |
|
2536
First Trust NASDAQ 100 ex-Technology Sector Index Fund
QQXT
$1.1B
| $2.27M | ﹤0.01% |
22,933
-95
| -0.4% | -$9.39K |
|
2537
John B. Sanfilippo & Son
JBSS
$754M
| $2.26M | ﹤0.01% |
35,797
-2,730
| -7% | -$173K |
|
2538
Cable One
CABO
$961M
| $2.26M | ﹤0.01% |
16,647
-40,859
| -71% | -$5.55M |
|
2539
HUB Group
HUBG
$2.3B
| $2.26M | ﹤0.01% |
67,625
-44,163
| -40% | -$1.48M |
|
2540
iShares Russell Top 200 Growth ETF
IWY
$15.4B
| $2.26M | ﹤0.01% |
9,153
-24,729
| -73% | -$6.1M |
|
2541
Axon Enterprise
AXON
$59B
| $2.26M | ﹤0.01% |
2,725
-70,316
| -96% | -$58.2M |
|
2542
Icahn Enterprises
IEP
$4.69B
| $2.26M | ﹤0.01% |
+280,406
| New | +$2.26M |
|
2543
Acrivon Therapeutics
ACRV
$49.1M
| $2.26M | ﹤0.01% |
1,895,519
| – | – |
|
|
SION
2544
Sionna Therapeutics, Inc. Common Stock
SION
$1.03B
| $2.25M | ﹤0.01% |
129,912
-196,588
| -60% | -$3.41M |
|
2545
United States Natural Gas Fund
UNG
$602M
| $2.25M | ﹤0.01% |
147,317
-256,149
| -63% | -$3.91M |
|
2546
FT Vest Growth-100 Buffer ETF December
QDEC
$521M
| $2.25M | ﹤0.01% |
76,560
+17,839
| +30% | +$523K |
|
2547
New Fortress Energy
NFE
$615M
| $2.24M | ﹤0.01% |
675,789
-908,740
| -57% | -$3.02M |
|
|
MSSM
2548
Morgan Stanley Pathway Small-Mid Cap Equity ETF
MSSM
$682M
| $2.24M | ﹤0.01% |
+48,088
| New | +$2.24M |
|
2549
MaxCyte
MXCT
$158M
| $2.24M | ﹤0.01% |
1,028,075
+790,433
| +333% | +$1.72M |
|
2550
Afya
AFYA
$1.45B
| $2.24M | ﹤0.01% |
125,339
+39,951
| +47% | +$714K |
|